Biotech stock considered as Sp_老虎社区_美港股上老虎

2021-08-04

Biotech stock considered as Speculative or Cyclical or others?

SoftBank Builds a $5 Billion Stake in Pharma Giant Roche

免责声明：上述内容仅代表发帖人个人观点，不构成本平台的任何投资建议。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"detailType":1,"isChannel":false,"data":{"magic":2,"id":807655775,"tweetId":"807655775","gmtCreate":1628036184897,"gmtModify":1633754235284,"author":{"id":3586917113767701,"idStr":"3586917113767701","authorId":3586917113767701,"authorIdStr":"3586917113767701","name":"Idz4u2c","avatar":"https://static.tigerbbs.com/e4c0686647ad0cc4a1d78423e4487fc9","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":9,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"extraTitle":"","html":"<html><head></head><body><p>Biotech stock considered as Speculative or Cyclical or others?</p></body></html>","htmlText":"<html><head></head><body><p>Biotech stock considered as Speculative or Cyclical or others?</p></body></html>","text":"Biotech stock considered as Speculative or Cyclical or others?","highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":2,"repostSize":0,"favoriteSize":0,"link":"https://laohu8.com/post/807655775","repostId":2156209941,"repostType":4,"repost":{"id":"2156209941","pubTimestamp":1628035381,"share":"https://www.laohu8.com/m/news/2156209941?lang=&edition=full","pubTime":"2021-08-04 08:03","market":"us","language":"en","title":"SoftBank Builds a $5 Billion Stake in Pharma Giant Roche","url":"https://stock-news.laohu8.com/highlight/detail?id=2156209941","media":"Bloomberg","summary":"Japanese firm’s stake makes it one of Roche’s top investors\nSoftBank believes Roche’s Genentech divi","content":"<ul>\n <li>Japanese firm’s stake makes it one of Roche’s&nbsp;top investors</li>\n <li>SoftBank believes Roche’s Genentech division is undervalued</li>\n</ul>\n<p>SoftBank Group Corp. has quietly built a $5 billion stake in Roche Holding AG, placing a bet on the pharmaceutical company’s strategy of using data to develop drugs, according to people familiar with the matter.</p>\n<p>The Japanese conglomerate is now <a href=\"https://laohu8.com/S/AONE.U\">one</a> of Roche’s largest investors, according to data compiled by Bloomberg.</p>\n<p>Roche’s sales have recently been boosted by its Covid-19 testing business. The company’s diagnostics unit reacted swiftly to the coronavirus pandemic, but the pharmaceuticals division, where aging cancer medicines face increasing competition, has had a more difficult time.</p>\n<p>Shares of the Basel, Switzerland-based company have risen 8.8% in the last 12 months, compared with a 14.7% gain in the MSCI World Pharma Biotech &amp; Life Sciences index over the same period.</p>\n<p>The drugmaker has a dual-class share structure with separate voting and non-voting shares. The founding families own 50.1% of the voting class, while cross-town rival Novartis AG holds one-third. It’s unclear which types of shares SoftBank holds.</p>\n<p>SoftBank believes Roche’s Genentech division, which focuses on data-based drug discovery and development, is highly undervalued, one of the people said, all of whom asked not to be identified because the information is private. Roche last year hired Aviv Regev, a computational and systems biologist who was a core member of the Harvard University-affiliated Broad Institute, to lead the Genetech research unit.</p>\n<p>Roche is also developing a new pill for Covid-19 and an Alzheimer’s disease treatment. In June, the U.S. approved Biogen Inc.’s Alzheimer’s drug Aduhelm, which was seen as a positive sign for the Roche medicine.</p>\n<p>SoftBank has been increasingly focused on biotech and health care. It invested in Pacific Biosciences of California Inc., <a href=\"https://laohu8.com/S/ABCL\">AbCellera Biologics</a> and Sana Biotechnology. In February, Bloomberg News reported that SoftBank was planning to spend billions investing in public biotech companies, via its asset management arm SB Northstar.</p>","source":"lsy1584095487587","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>SoftBank Builds a $5 Billion Stake in Pharma Giant Roche</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nSoftBank Builds a $5 Billion Stake in Pharma Giant Roche\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-08-04 08:03 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.bloomberg.com/news/articles/2021-08-03/softbank-is-said-to-build-5-billion-stake-in-pharma-giant-roche?srnd=premium-asia><strong>Bloomberg</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Japanese firm’s stake makes it one of Roche’s top investors\nSoftBank believes Roche’s Genentech division is undervalued\n\nSoftBank Group Corp. has quietly built a $5 billion stake in Roche Holding AG, ...</p>\n\n<a href=\"https://www.bloomberg.com/news/articles/2021-08-03/softbank-is-said-to-build-5-billion-stake-in-pharma-giant-roche?srnd=premium-asia\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"AMZN":"亚马逊","RHHBF":"Roche Holding Ltd","SFTBY":"软银集团","MSFT":"微软","PACB":"Pacific Biosciences of Californi","BIIB":"渤健公司","RHHBY":"罗氏控股"},"source_url":"https://www.bloomberg.com/news/articles/2021-08-03/softbank-is-said-to-build-5-billion-stake-in-pharma-giant-roche?srnd=premium-asia","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2156209941","content_text":"Japanese firm’s stake makes it one of Roche’s top investors\nSoftBank believes Roche’s Genentech division is undervalued\n\nSoftBank Group Corp. has quietly built a $5 billion stake in Roche Holding AG, placing a bet on the pharmaceutical company’s strategy of using data to develop drugs, according to people familiar with the matter.\nThe Japanese conglomerate is now one of Roche’s largest investors, according to data compiled by Bloomberg.\nRoche’s sales have recently been boosted by its Covid-19 testing business. The company’s diagnostics unit reacted swiftly to the coronavirus pandemic, but the pharmaceuticals division, where aging cancer medicines face increasing competition, has had a more difficult time.\nShares of the Basel, Switzerland-based company have risen 8.8% in the last 12 months, compared with a 14.7% gain in the MSCI World Pharma Biotech & Life Sciences index over the same period.\nThe drugmaker has a dual-class share structure with separate voting and non-voting shares. The founding families own 50.1% of the voting class, while cross-town rival Novartis AG holds one-third. It’s unclear which types of shares SoftBank holds.\nSoftBank believes Roche’s Genentech division, which focuses on data-based drug discovery and development, is highly undervalued, one of the people said, all of whom asked not to be identified because the information is private. Roche last year hired Aviv Regev, a computational and systems biologist who was a core member of the Harvard University-affiliated Broad Institute, to lead the Genetech research unit.\nRoche is also developing a new pill for Covid-19 and an Alzheimer’s disease treatment. In June, the U.S. approved Biogen Inc.’s Alzheimer’s drug Aduhelm, which was seen as a positive sign for the Roche medicine.\nSoftBank has been increasingly focused on biotech and health care. It invested in Pacific Biosciences of California Inc., AbCellera Biologics and Sana Biotechnology. In February, Bloomberg News reported that SoftBank was planning to spend billions investing in public biotech companies, via its asset management arm SB Northstar.","news_type":1},"isVote":1,"tweetType":1,"viewCount":83,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":[],"verified":2,"subType":0,"readableState":1,"langContent":"EN","currentLanguage":"EN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":54,"xxTargetLangEnum":"ORIG"},"commentList":[],"isCommentEnd":true,"isTiger":false,"isWeiXinMini":false,"url":"/m/post/807655775"}